Our newest service provides subscribers a daily newsletter of current reports (Form 8-K) filed with the Securities and Exchange Commission, all categorized by the triggering events cited by the company. Below is a list of the current reports that we've tracked in the last seven days that cited triggering events that accelerate or increase a direct financial obligation or an obligation under an off-balance sheet arrangement (Item 2.04):
Gala Pharmaceutical Inc.
ALDER BIOPHARMACEUTICALS INC
Our subscribers received notification of these filings - as well as all other current reports - each morning in a highly-efficient newsletter format. Subscriptions start at only $9.00 per month and we offer a 14-day free trial. Learn more and sign up for a trial by clicking the image below.
Current Reports (Form 8-K) Filed With the Securities & Exchange Commission (SEC) Regarding Triggering Events That Accelerate or Increase a Direct Financial Obligation (Item 2.04) for the Week Ended Wednesday Oct 23, 2019
← Older Post Newer Post →